Skip to main navigation Skip to search Skip to main content

Anagliptin twice-daily regimen improves glycaemic variability in subjects with type 2 diabetes: A double-blind, randomized controlled trial

  • the ACACIA Study Group

    Research output: Contribution to journal › Article › peer-review

    5   Link opens in a new tab Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Anagliptin twice-daily regimen improves glycaemic variability in subjects with type 2 diabetes: A double-blind, randomized controlled trial'. Together they form a unique fingerprint.
    Sort by

    Medicine and Dentistry

    Nursing and Health Professions

    Pharmacology, Toxicology and Pharmaceutical Science